Diabetologia

Article	Citations
Not all very-low-carbohydrate diets are created equal. Reply to Conte C, Camajani E, Lai A, Caprio M [letter]	513
Brown adipose tissue alleviates podocyte apoptosis through NRG4 in a male mouse model of diabetic kidney disease	219
Genome-wide association study identifying novel risk variants associated with glycaemic traits in the continental African AWI-Gen cohort	202
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter]	199
Cardiac arrhythmia and hypoglycaemia among individuals with and without diabetes receiving haemodialysis (the CADDY study): a Danish multicentre cohort study	180
Plasma metabolite profiles related to plant-based diets and the risk of type 2 diabetes	159
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial	130
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question. Reply to Kanter M [letter]	128
High glucose/ChREBP-induced Hif-1α transcriptional activation in CD4+ T cells reduces the risk of diabetic kidney disease by inhibiting the Th1 response	115
The insulin hypersecretion hypothesis: cause or effect? Reply to Polychronakos C [letter]	104
Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia	103
Potential confounders in the association between per- and polyfluoroalkyl substance exposure and diabetes	103
58th EASD Annual Meeting of the European Association for the Study of Diabetes	102
Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascu	96
Up Front	95
Determination of autoantibodies in type 2 diabetes: one simple way to improve classification	87
Up Front	87
Scientists and scientific journals should adhere to ethical standards for the use and reporting of data from Indigenous people	74
Presymptomatic type 1 diabetes and disease severity at onset. Reply to Schneider J, Gemulla G, Kiess W et al [letter]	73
Higher maternal adiposity reduces offspring birthweight if associated with a metabolically favourable profile	73
Transcriptomic heterogeneity of non-beta islet cells is associated with type 2 diabetes development in mouse models	70
Characterisation of enterovirus RNA detected in the pancreas and other specimens of live patients with newly diagnosed type 1 diabetes in the DiViD study	69
Gut microbiota mediate melatonin signalling in association with type 2 diabetes	68
Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT	68
Up Front	66

Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study	65
Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency	65
Effectiveness and safety of empagliflozin: final results from the EMPRISE study	64
The efficacy of islet autoantibody screening with or without genetic pre-screening strategies for the identification of presymptomatic type 1 diabetes	63
The gut microbiota and diabetes: clarity on an emerging topic and introduction to a new partnership and journal feature	62
57 th EASD Annual Meeting of the European Association for the Study of Diabetes	61
Environmental exposures are important for type 2 diabetes pathophysiology in sub-Saharan African populations	57
Up Front	57
Young age at diabetes diagnosis amplifies the effect of diabetes duration on risk of chronic kidney disease: a prospective cohort study	56
Up Front	56
Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering	55
HAND2 is a novel obesity-linked adipogenic transcription factor regulated by glucocorticoid signalling	55
Identification and interpretation of risk factors for Charcot foot. Reply to Milbourn VEL, Bus SA, Game F, van Netten JJ [letter]	54
Diabetes knowledge and behaviour: a cross-sectional study of Jordanian adults	54
Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review	53
Causal factors underlying diabetes risk informed by Mendelian randomisation analysis: evidence, opportunities and challenges	51
Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes	51
Infant gut microbiome composition correlated with type 1 diabetes acquisition in the general population: the ABIS study	50
Not all very-low-carbohydrate diets are created equal	49
Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort stu	49
Plasma proteomic signatures of a direct measure of insulin sensitivity in two population cohorts	49
Incretins beyond type 2 diabetes	48
Comments on the notion of false positivity in measurements of autoantibodies	47
Atorvastatin lowers 68Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes	47
Using race as a social construct when looking at differences in racial associations between non-alcoholic fatty liver disease and type 2 diabetes	47
Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study	46
Non-invasive imaging of sympathetic innervation of the pancreas in individuals with type 2 diabetes	45
Acculturation and glycaemic control in Arab immigrants with type 2 diabetes in Australia	45
Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled	44
Morning exercise as fasted-state activity	44
Low birthweight and overweight during childhood and young adulthood and the risk of type 2 diabetes in men: a population-based cohort study	44
Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes	43
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study	42
Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials	42
Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation	41
Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca2+ dynamics in prediabetic beta cells	41
Correction: Discovery and validation of plasma, saliva and multi-fluid plasma–saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults	40
Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes	40
Single-cell transcriptomic profiling of human pancreatic islets reveals genes responsive to glucose exposure over 24 h	40
The SWI/SNF chromatin remodelling complex regulates pancreatic endocrine cell expansion and differentiation in mice in vivo	39
Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers	38
Longitudinal metabolite and protein trajectories prior to diabetes mellitus diagnosis in Danish blood donors: a nested case–control study	38
The Type 1 Diabetes T Cell Receptor and B Cell Receptor Repository in the AIRR Data Commons: a practical guide for access, use and contributions through the Type 1 Diabetes AIRR Consortium	38
Spatial proteomics of human diabetic kidney disease, from health to class III	38
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care	38
Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic study	37
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab	37
The oxylipin profile is associated with development of type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY)	37
The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled cross	36
Risk factors and incidence over time for lower extremity amputations in people with type 1 diabetes: an observational cohort study of 46,088 patients from the Swedish National Diabetes Registry	36

Pre-pregnancy menstrual cycle regularity and length and the risk of gestational diabetes mellitus: prospective cohort study	36
Physical activity attenuates postprandial hyperglycaemia in homozygous TBC1D4 loss-of-function mutation carriers	36
Local islet remodelling associated with duct lesion–islet complex in adult human pancreas	36
The second-generation antipsychotic drug aripiprazole modulates the serotonergic system in pancreatic islets and induces beta cell dysfunction in female mice	34
Assessing the linear and non-linear association of HbA1c with cardiovascular disease: a Mendelian randomisation study	34
Spatial and transcriptional heterogeneity of pancreatic beta cell neogenesis revealed by a time-resolved reporter system	34
Wt1 haploinsufficiency induces browning of epididymal fat and alleviates metabolic dysfunction in mice on high-fat diet	34
MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway	34
MAIT cell alterations in adults with recent-onset and long-term type 1 diabetes	34
The insulin market reaches 100	33
Birthweight, BMI in adulthood and latent autoimmune diabetes in adults: a Mendelian randomisation study	33
A miR-125/Sirtuin-7 pathway drives the pro-calcific potential of myeloid cells in diabetic vascular disease	33
Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study	33
No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM study	32
Changes in the gut bacteriome upon gluten-free diet intervention do not mediate beta cell preservation	32
Risk of kidney disease following a pregnancy complicated by diabetes: a longitudinal, population-based data-linkage study among Aboriginal women in the Northern Territory, Australia	32
Temporal trends in the prevalence and incidence of depression and the interplay of comorbidities in patients with young- and usual-onset type 2 diabetes from the USA and the UK	32
Proteomic analysis of diabetes genetic risk scores identifies complement C2 and neuropilin-2 as predictors of type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) Study	32
Health and economic impact of improved glucose, blood pressure and lipid control among German adults with type 2 diabetes: a modelling study	31
The effect of surgical weight loss on diabetes complications in individuals with class II/III obesity	31
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory	31
Drug target Mendelian randomisation: are we really instrumenting drug use? Reply to Anderson EL, Williams DM [letter]	31
RELA governs a network of islet-specific metabolic genes necessary for beta cell function	30
Gain of pancreatic beta cell-specific SCD1 improves glucose homeostasis by maintaining functional beta cell mass under metabolic stress	30
Correction to: Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function	30
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes	30
Correction to: Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy	30
TBC1D30 regulates proinsulin and insulin secretion and is the target of a genomic association signal for proinsulin	30
Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial	30
Correction to: The suitability of patient-reported outcome measures used to assess the impact of hypoglycaemia on quality of life in people with diabetes: a systematic review using COSMIN methods	30
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data	29
Metabolic traits affecting the relationship between liver fat and intrapancreatic fat: a mediation analysis	29
Type 2 diabetes burden among migrants in Europe: unravelling the causal pathways	29
The impact of taxing sugar-sweetened beverages on diabetes: a critical review	28
The future is here: an overview of technology in diabetes	28
Detection of enterovirus RNA in pancreas and lymphoid tissues of organ donors with type 1 diabetes	28
Up Front	28
60th EASD Annual Meeting of the European Association for the Study of Diabetes	28
Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies	28
Presymptomatic type 1 diabetes and disease severity at onset	28
Comprehensive sequencing profile and functional analysis of IsomiRs in human pancreatic islets and beta cells	28
Markers of metabolic health and gut microbiome diversity: findings from two population-based cohort studies	27
Disruption of retinal inflammation and the development of diabetic retinopathy in mice by a CD40-derived peptide or mutation of CD40 in Müller cells	27
Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants	27
Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor	27
The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)	26
Early DNA methylation changes in children developing beta cell autoimmunity at a young age	26
A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab	26
Insulin allergy: a diagnostic and therapeutic strategy based on a retrospective cohort and a case–control study	26
Paediatric diabetes subtypes in a consanguineous population: a single-centre cohort study from Kurdistan, Iraq	26
IFNɣ but not IFNα increases recognition of insulin defective ribosomal product-derived antigen to amplify islet autoimmunity	25
ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis	25
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities	25
A polygenic risk score derived from common variants of monogenic diabetes genes is associated with young-onset type 2 diabetes and cardiovascular–kidney complications	25
Multi-ethnic GWAS and fine-mapping of glycaemic traits identify novel loci in the PAGE Study	25
Prediabetes, intervening diabetes and subsequent risk of dementia: the Atherosclerosis Risk in Communities (ARIC) study	25
Child-to-adult body size change and risk of type 2 diabetes and cardiovascular disease	24
Quinine: rediscovery of an old glucose-lowering drug	24
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials	24
Ageing well with diabetes: the role of technology	24
Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies	24
Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review	24
Loneliness increases the risk of type 2 diabetes: a 20 year follow-up – results from the HUNT study	24
Prediabetes blunts DPP4 genetic control of postprandial glycaemia and insulin secretion	23
Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: a randomised crossover trial	23
Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade	23
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes	23
Sugar-sweetened or artificially sweetened beverage consumption, physical activity and risk of type 2 diabetes in US adults	23
Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts	23
Deletion of RFX6 impairs iPSC-derived islet organoid development and survival, with no impact on PDX1+/NKX6.1+ progenitors	23
Monounsaturated fatty acids from plant or animal sources and risk of type 2 diabetes in three large prospective cohorts of men and women	23
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control	23
Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy	23
The expanding incretin universe: from basic biology to clinical translation	22
Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review	22
The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes	22
Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment	22
Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops	22
Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register	22
SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study	22

The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study	22
Lifestyle interventions in pregnancy targeting GDM prevention: looking ahead to precision medicine	22
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes	22
Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes	21
Glucose tolerance and insulin resistance/sensitivity associate with retinal layer characteristics: the LIFE-Adult-Study	21
Retinal microvascular associations with cardiometabolic risk factors differ by diabetes status: results from the UK Biobank	21
Up front	21
Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes	21
Sex differences in type 2 diabetes	21
A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk	21
Pathophysiology of type 2 diabetes in sub-Saharan Africans	21
Glucose-lowering effects of a synbiotic combination containing Pediococcus acidilactici in C. elegans and mice	21
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes	21
Up Front	21
Pancreatic alpha cell glucagon–liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes	21
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease	20
Sarah A. Hills RGN MSc, 28 September 1960–1 May 2023	20
Up Front	20
Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research	20
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention	20
Loss of RREB1 in pancreatic beta cells reduces cellular insulin content and affects endocrine cell gene expression	20
IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes	20
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia?	20
Continuous glucose monitoring and hypoglycaemia events: unmet needs	20
Dysregulated 24 h melatonin secretion associated with intrinsically photosensitive retinal ganglion cell function in diabetic retinopathy: a cross-sectional study	20
Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study	19
Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled stu	19
Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes	19
Up Front	19
Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis	19
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question	19
Up front	18
Correction to: The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis	18
Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised tr	18
Up front	18
Correction to: Pancreatic T cell protein–tyrosine phosphatase deficiency affects beta cell function in mice	18
Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults. Reply to Sugiyama K and Saisho Y [lette	18
Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study	18
Pinpointing precision medicine for diabetes mellitus	17
Leveraging human genetic data to investigate the cardiometabolic effects of glucose-dependent insulinotropic polypeptide signalling	17
Correction: Islet autoantibodies in Thai individuals diagnosed with type 1 diabetes before 30 years of age: a large multicentre nationwide study	17
Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control	17
Precision medicine in type 1 diabetes	17
Correction to: Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial	17
Up Front	16
Diabetic pregnancy as a novel risk factor for cardiac dysfunction in the offspring—the heart as a target for fetal programming in rats	16
Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults	16
Ertugliflozin, renoprotection and potential confounding by muscle wasting	16
Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabete	16
Donor insulin use during stay in the intensive care unit should not preclude pancreas transplantation	16
Sex differences in intraorgan fat levels and hepatic lipid metabolism: implications for cardiovascular health and remission of type 2 diabetes after dietary weight loss	16
Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver	16
Association between weight change and incidence of cardiovascular disease events and mortality among adults with type 2 diabetes: a systematic review of observational studies and behavioural intervent	16
Up Front	16
Does nocturnal hypoglycaemia really improve quality of life?	16
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes: Reply to Johnson JD [letter]	16
Activated but functionally impaired memory Tregs are expanded in slow progressors to type 1 diabetes	16
Systematic genetic testing for recessively inherited monogenic diabetes: a cross-sectional study in paediatric diabetes clinics	16
Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies	15
Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women	15
Missing the forest-plot for the trees	15
Sex-specific effects of maternal metformin intervention during glucose-intolerant obese pregnancy on body composition and metabolic health in aged mouse offspring	15
The insulin hypersecretion hypothesis: cause or effect?	15
The 26RFa (QRFP)/GPR103 neuropeptidergic system in mice relays insulin signalling into the brain to regulate glucose homeostasis	15
Smoking, use of smokeless tobacco, HLA genotypes and incidence of latent autoimmune diabetes in adults	15
Investigating mortality in the association between depression and diabetes	15
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open	15
Effects of progressive resistance training in individuals with type 2 diabetic polyneuropathy: a randomised assessor-blinded controlled trial	15
Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?	15
Continuous glucose monitoring and hypoglycaemia events: unmet needs. Reply to Papaioannou TG, Snoudou D and Tsiofis C [letter]	15
Secular trend for increasing birthweight in offspring of pregnant women with type 1 diabetes: is improved placentation the reason?	15
Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data	15
Opposing effects on regulated insulin secretion of acute vs chronic stimulation of AMP-activated protein kinase	15
Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset	14
Identifying the severity of diabetic retinopathy by visual function measures using both traditional statistical methods and interpretable machine learning: a cross-sectional study	14
Quantifying beta cell function in the preclinical stages of type 1 diabetes	14
Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1α	14
CK2 activity is crucial for proper glucagon expression	14
Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis	14
An unwelcome inheritance: childhood obesity after diabetes in pregnancy	14
Continuous glucose monitoring-derived time in range and CV are associated with altered tissue characteristics of the carotid artery wall in people with type 2 diabetes	14
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists	14
Correction to: Occurrence of corneal sub-epithelial microneuromas and axonal swelling in people with diabetes with and without (painful) diabetic neuropathy	14
The incidence of childhood-onset type 1 diabetes, time trends and association with the population composition in Sweden: a 40 year follow-up	14
Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetes	14
Retinal inflammation in murine models of type 1 and type 2 diabetes with diabetic retinopathy	14
A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective	14
Morning exercise as fasted-state activity. Reply to Chacko E [letter]	14
Genetic associations vary across the spectrum of fasting serum insulin: results from the European IDEFICS/I.Family children’s cohort	14